Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite.

Saifullah B, Hussein MZ, Hussein-Al-Ali SH, Arulselvan P, Fakurazi S.

Chem Cent J. 2013 Apr 20;7(1):72. doi: 10.1186/1752-153X-7-72.

2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
3.
4.

Development of a highly biocompatible antituberculosis nanodelivery formulation based on para-aminosalicylic acid-zinc layered hydroxide nanocomposites.

Saifullah B, Arulselvan P, El Zowalaty ME, Fakurazi S, Webster TJ, Geilich B, Hussein MZ.

ScientificWorldJournal. 2014;2014:401460. doi: 10.1155/2014/401460. Epub 2014 Jun 23.

5.

Preparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell lines.

Hussein Al Ali SH, Al-Qubaisi M, Hussein MZ, Zainal Z, Hakim MN.

Int J Nanomedicine. 2011;6:3099-111. doi: 10.2147/IJN.S24510. Epub 2011 Dec 1.

6.

Herbicide-intercalated zinc layered hydroxide nanohybrid for a dual-guest controlled release formulation.

Hussein MZ, Rahman NS, Sarijo SH, Zainal Z.

Int J Mol Sci. 2012;13(6):7328-42. doi: 10.3390/ijms13067328. Epub 2012 Jun 13.

7.

Antituberculosis nanodelivery system with controlled-release properties based on para-amino salicylate-zinc aluminum-layered double-hydroxide nanocomposites.

Saifullah B, Hussein MZ, Hussein-Al-Ali SH, Arulselvan P, Fakurazi S.

Drug Des Devel Ther. 2013 Nov 13;7:1365-75. doi: 10.2147/DDDT.S50665. eCollection 2013.

8.

Controlled-release approaches towards the chemotherapy of tuberculosis.

Saifullah B, Hussein MZ, Hussein Al Ali SH.

Int J Nanomedicine. 2012;7:5451-63. doi: 10.2147/IJN.S34996. Epub 2012 Oct 12.

9.

Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent.

Kura AU, Hussein Al Ali SH, Hussein MZ, Fakurazi S, Arulselvan P.

Int J Nanomedicine. 2013;8:1103-10. doi: 10.2147/IJN.S39740. Epub 2013 Mar 16.

10.

Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.

Hussein Al Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN.

Int J Nanomedicine. 2012;7:2129-41. doi: 10.2147/IJN.S30461. Epub 2012 Apr 24.

11.

Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells.

Hasan S, Al Ali H, Al-Qubaisi M, Zobir Hussein M, Ismail M, Zainal Z, Nazrul Hakim M.

Int J Nanomedicine. 2012;7:3351-63. doi: 10.2147/IJN.S30809. Epub 2012 Jul 3.

12.

Synthesis of (cinnamate-zinc layered hydroxide) intercalation compound for sunscreen application.

Mohsin SM, Hussein MZ, Sarijo SH, Fakurazi S, Arulselvan P, Hin TY.

Chem Cent J. 2013 Feb 6;7(1):26. doi: 10.1186/1752-153X-7-26.

13.
14.

Anticancer nanodelivery system with controlled release property based on protocatechuate-zinc layered hydroxide nanohybrid.

Barahuie F, Hussein MZ, Abd Gani S, Fakurazi S, Zainal Z.

Int J Nanomedicine. 2014 Jun 26;9:3137-49. doi: 10.2147/IJN.S59541. eCollection 2014.

15.

Development of a biocompatible nanodelivery system for tuberculosis drugs based on isoniazid-Mg/Al layered double hydroxide.

Saifullah B, Arulselvan P, El Zowalaty ME, Fakurazi S, Webster TJ, Geilich BM, Hussein MZ.

Int J Nanomedicine. 2014 Oct 9;9:4749-62. doi: 10.2147/IJN.S63608. eCollection 2014.

16.

Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent.

Hussein MZ, Al Ali SH, Zainal Z, Hakim MN.

Int J Nanomedicine. 2011;6:1373-83. doi: 10.2147/IJN.S21567. Epub 2011 Jul 4.

17.

Antimycobacterial, antimicrobial, and biocompatibility properties of para-aminosalicylic acid with zinc layered hydroxide and Zn/Al layered double hydroxide nanocomposites.

Saifullah B, El Zowalaty ME, Arulselvan P, Fakurazi S, Webster TJ, Geilich BM, Hussein MZ.

Drug Des Devel Ther. 2014 Jul 28;8:1029-36. doi: 10.2147/DDDT.S63753. eCollection 2014.

18.

Release behavior and toxicity profiles towards A549 cell lines of ciprofloxacin from its layered zinc hydroxide intercalation compound.

Abdul Latip AF, Hussein MZ, Stanslas J, Wong CC, Adnan R.

Chem Cent J. 2013 Jul 12;7:119. doi: 10.1186/1752-153X-7-119. eCollection 2013.

19.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
20.

Slow release anti-fungal skin formulations based on citric acid intercalated layered double hydroxides nanohybrids.

Perera J, Weerasekera M, Kottegoda N.

Chem Cent J. 2015 May 21;9:27. doi: 10.1186/s13065-015-0106-3. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk